PARIS - Flamel Technologies SA and Bristol-Myers Squibb Co. signed a licensing and commercialization agreement covering Flamel's human insulin product, Basulin. (BioWorld International) Read More
WASHINGTON – Federal health officials in Washington and Ottawa, Canada, are reaching across borders to collaborate on what could be a precedent of how research is conducted in the future. (Medical Device Daily) Read More
